About 93,900 results

ALLMedicine™ Headache Center

Research & Reviews  20,857 results

Fundus imaging and perimetry in patients with idiopathic intracranial hypertension - an...
European Journal of Neurology; Rissan Z, Hansen NS et. al.

Mar 28th, 2023 - There is a need to improve the diagnostic process of patients suspected of papilledema. In patients with known or suspected idiopathic intracranial hypertension we validated a fundus imaging and perimetric visual field assessment system (COMPASS) ...

Effects of diacutaneous fibrolysis in patients with tension-type headache: A randomized...
PloS One; Cabanillas-Barea S, Pérez-Guillén S et. al.

Mar 28th, 2023 - Manual therapy appears to be effective for the relief of tension-type headache (TTH), just as diacutaneous fibrolysis (DF) has shown to be a beneficial technique for the relief of symptoms in other dysfunctions. However, no studies have evaluated ...

Comparative efficacy and safety of combination therapy with infliximab for Crohn's dise...
International Journal of Colorectal Disease; Han B, Tang D et. al.

Mar 28th, 2023 - There is not enough information to position medications for the treatment of Crohn's disease (CD). Therefore, using a network meta-analysis and systematic review, we evaluated the efficacy and safety of combination therapy and infliximab (IFX) mon...

Diagnosis, knowledge, perception, and productivity impact of headache education and cli...
Cephalalgia : an International Journal of Headache; Sakai F, Igarashi H et. al.

Mar 28th, 2023 - Migraine is a highly prevalent, disabling, misunderstood, underdiagnosed, and undertreated neurological disease. It is a leading cause of productivity loss in the workplace. This is the first large-scale company-wide headache education and evaluat...

Effect of a three-day course of dexamethasone on acute phase response following treatme...
Journal of Bone and Mineral Research : the Official Journ... Murdoch R, Mellar A et. al.

Mar 28th, 2023 - Zoledronate is a potent intravenous bisphosphonate effective in the management of osteoporosis, Paget's disease and skeletal-related events in malignancy. Its most frequent adverse effect is the acute phase response (APR), an inflammatory reaction...

see more →

Guidelines  34 results

Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews
BMJ Ferreira G E, Abdel-Shaheed C et. al.

Feb 1st, 2023 - Chronic pain is common and debilitating, affecting about one in five people globally.1234 Musculoskeletal conditions such as back pain are typically the most common conditions leading to chronic pain, followed by headache, orofacial pain, and visc...

Multimorbidity and Sickness Absence/Disability Pension in Cluster Headache Patients and Matched References: A Swedish Register-Based Study
Neurology Ran C, .

Dec 14th, 2022 - Background: Multimorbidity among cluster headache (CH) patients is considered to be high, but large studies are lacking. The aims were to explore the occurrence of diagnosis-specific multimorbidity among CH patients and matched references and poss...

Headaches in Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 3.
Obstetrics and Gynecology;

May 17th, 2022 - To provide updated evidence-based recommendations for the evaluation and treatment of primary and secondary headaches in pregnancy and postpartum. Pregnant and postpartum patients with a history of or experiencing primary or new secondary headache...

Nutritional Approaches for Musculoskeletal Pain and Inflammation: What the Science Says
NCCIH Clinical Digestfor Health Professionals;

Feb 28th, 2022 - Willow bark has been used for centuries as a treatment for pain, headache, and inflammatory conditions such as bursitis and tendinitis. The bark of white willow contains salicin, the chemical that was used to develop aspirin. Despite its long hist...

Nervous system consequences of COVID-19
Science Spudich S, Nath A.

Jan 20th, 2022 - Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered a respiratory pathogen, myriad neurologic complications—including confusion, stroke, and neuromuscular disorders—manifest during acute COVID-19. Furthermore, malad...

see more →

Drugs  8,290 results see all →

Clinicaltrials.gov  2,063 results

Eptinezumab in Participants With Episodic Cluster Headache

Mar 16th, 2023 - Eligible participants will be randomly assigned to receive treatment, in a blinded manner, two infusions of either eptinezumab or placebo in a cross-over manner during the Placebo-controlled Period and Active Treatment Period of the study. The tot...

Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

Mar 15th, 2023 - The proposed study will be a randomized, open-label, comparator controlled study investigating the safety and efficacy of Botox in Persistent Post "Stroke" (encompassing ischemic stroke, hemorrhagic stroke, CVST, Cervical Vessel Dissection and RCV...

Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)

Mar 10th, 2023 - Healsea® Children is a seawater-based nasal spray supplemented with a natural Symbiofilm® extract (0.02%) isolated from marine bacteria. Symbiofilm® is an exopolymeric composition with emulsifying properties, in vitro antibiofilm activity and deta...

NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)

Mar 10th, 2023 - Study Description: This protocol is part of a joint collaboration with the Veterans Administration (VA) known as (Project IN-DEPTH). The Veterans Administration protocol will recruit and identify participants for the NIH study, and maintain a repo...

Efficacy of Wet Cupping Therapy on Fibromyalgia

Mar 9th, 2023 - Background: Cupping therapy is a traditional treatment method especially belonging to our geography. In addition to being on the agenda as a traditional treatment method all over the world in recent years, it has also been the subject of an increa...

see more →

News  5,733 results

Long COVID Neurologic Symptoms Vary Based on Severity of Initial Infection

Mar 28th, 2023 - Two groups of long COVID patients -- those hospitalized for acute COVID, and those with mild SARS-CoV-2 infection who weren't hospitalized -- had different neurologic manifestations, prospective data showed. Long COVID patients who were hospitaliz...

FDA Greenlights First Drug for Rare Immunodeficiency Disease

Mar 27th, 2023 - The FDA approved leniolisib (Joenja) on Friday as the first treatment indicated for activated phosphoinositide 3-kinase delta syndrome (APDS), a rare genetic disorder that causes progressive primary immunodeficiency. Leniolisib, an oral small mole...

Pitolisant Safe and Effective in Children With Narcolepsy

Mar 24th, 2023 - Pitolisant (Wakix) in children ages 6 years and up led to clinically meaningful improvements in narcolepsy symptoms in a phase III trial. Among 110 kids with narcolepsy with or without cataplexy, excessive daytime sleepiness and cataplexy scores i...

Headache before the revolution: A clinician looks back
Jennie Smith

Mar 24th, 2023 - Headache treatment before the early 1990s was marked by decades of improvisation with mostly unapproved agents, followed by an explosion of scientific interest and new treatments developed specifically for migraine. For practicing neurologists tod.

Complaints of cough and fatigue

Mar 20th, 2023 - The history and findings in this case are suggestive of non–small cell lung cancer (NSCLC) large cell carcinoma. Lung cancer is the most common cancer worldwide and has the highest mortality rate of all cancers.

see more →

Patient Education  583 results see all →